ovarian cancer in 90 seconds
Published 5 years ago • 895 plays • Length 1:37Download video MP4
Download video MP3
Similar videos
-
1:36
comment: front-line osimertinib significantly lengthens overall survival in egfr-mutation positi...
-
1:30
dr. langer on afatinib for advanced non-small cell lung cancer
-
3:02
osimertinib for treating non-small cell lung cancer
-
0:55
tisagenlecleucel in r/r follicular lymphoma: elara data
-
1:34
the effect of lfa-1 knockout on tumor growth and treg cells
-
2:52
asj article highlights-clayton moliver on endotoxins, red breast and hand syndrome
-
1:15
dr. kalinksy on pcr as a surrogate marker for efs in tnbc
-
16:39
rf-ace for uncovering nonlinear associations from heterogeneous cancer data - timo erkkilä
-
1:38
low grade ovarian cancer – clinical and molecular aspects
-
0:31
immune cell contexture at the single cell level
-
25:25
webinar | latest developments in ovarian cancer: dr yoland antill
-
3:31
osimertinib plus gefitinib for treatment of egfr-mutated non-small cell lung cancer
-
48:27
dr. aldrin lie tze min : understanding infertility
-
0:53
burst secretion of antibodies from a hybridoma cell
-
28:59
high throughput secretomic analysis of single cells for systems immunology
-
1:37
dr. scagliotti discusses egfr mutations in nsclc
-
2:14
lux-lung 7: phase 2b trial of first-line afatinib versus gefitinib for egfr mutation-positive nsclc
-
9:37
small cell carcinoma of ovary-hypercalcemic type
-
1:33
tracking non-small cell lung cancer evolution through therapy (rx) (tracerx)